Hepatitis D infection: from initial discovery to current investigational therapies
Ben L Da Theo Heller Christopher Koh
Gastroenterology Report, goz023, https://doi.org/10.1093/gastro/goz023
Published:
23 June 2019
Abstract
Hepatitis D is the most severe form of viral hepatitis associated with a more rapid progression to cirrhosis and an increased risk of hepatocellular carcinoma and mortality compared with hepatitis B mono-infection. Although once thought of as a disappearing disease, hepatitis D is now becoming recognized as a serious worldwide issue due to improvement in diagnostic testing and immigration from endemic countries. Despite these concerns, there is currently only one accepted medical therapy (pegylated-interferon-α) for the treatment of hepatitis D with less than desirable efficacy and significant side effects. Due to these reasons, many patients never undergo treatment. However, increasing knowledge about the virus and its life cycle has led to the clinical development of multiple promising new therapies that hope to alter the natural history of this disease and improve patient outcome. In this article, we will review the literature from discovery to the current investigational therapies. 作者: StephenW 时间: 2019-6-27 09:24
丁型肝炎感染：从最初的发现到目前的研究性治疗
Ben L Da Theo Heller Christopher Koh
胃肠病学报告，goz023，https：//doi.org/10.1093/gastro/goz023
发布时间：
2019年6月23日